ArticleJournal of gastroenterology2020
Durable response without recurrence to Tolvaptan improves long-term survival.
Masato Nakai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleJournal of gastroenterology2020
Masato Nakai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.